AGP Executive Report

NYSE Milestone: Trulieve became the first U.S. cannabis company to list on the New York Stock Exchange after medical marijuana was reclassified to Schedule III, signaling more mainstream legitimacy for the sector. Virginia Retail Push: Gov. Abigail Spanberger says talks are making “substantial” progress toward a bill to legalize and regulate recreational marijuana sales, with negotiations focused on launch timing and implementation resources. Regulation Tech: California regulators rolled out an AI “Cannabis Product Image Analyzer” to help businesses flag packaging that could appeal to kids, aiming to tighten compliance. Hemp Under Pressure: Texas hemp rules targeting smokable hemp are back in limbo after an appeals court denied an emergency request to keep an injunction, affecting enforcement of new consumable hemp regulations. EU Drug Warning: A new EU report says drug trafficking is fueling violence and public health harms, with more potent cannabis products and shifting routes raising risks. UK Medicinal Access Clash: A councillor’s partner avoided jail after a cannabis grow case was dropped, highlighting ongoing gaps between legal prescriptions and restrictions on home growing. Community & Safety: Minnesota’s Office of Cannabis Management held listening sessions to explain how it regulates the cannabis industry and prevention grants.

Medicinal Cannabis Driving Rules (Australia): NSW is moving toward a “medically prescribed THC” driving limit, proposing enforcement cutoffs at 50 ng/mL in saliva and a tiered response for repeat positives. Medical Access (Texas): Texas patients in the Compassionate Use Program can now use vaporization products for the first time, aiming for faster-acting options than edibles or tinctures. Public Health & Youth Vaping: USM/National Poison Centre warns vapes are increasingly being misused to consume drugs, including synthetic cannabis and fentanyl—raising detection and treatment challenges. EU Drug Market Risks: The EU Drugs Agency flags 50 new psychoactive substances in 2025, warns vapes may carry harmful substances, and notes highly potent cannabis and mixed-drug use driving overdose risk. Industry & Markets (Trulieve): Trulieve is set to list on the NYSE (TRLV) and authorized a share repurchase program, signaling momentum for U.S. cannabis finance. Safety/Compliance (Florida): A teacher and students reportedly tested positive after THC-laced cookies made kids sick; separate reporting also highlights water-runoff concerns tied to a Trulieve facility. Regulation Watch (Tennessee): A July 1 ban on THC products at 0.3%+ (including THCA-converted THC) tightens what hemp shoppers can buy.

Federal Rescheduling Watch: The DOJ/DEA move to reschedule medical marijuana (Schedule I to Schedule III) keeps reshaping travel and access rules, with TSA guidance now updated for air passengers. Hemp Crackdown: A proposed Illinois law would shut down unlicensed intoxicating hemp shops, adding pressure to hemp-derived CBD sleep aids, THC drinks, and THCA products. Retail Access Push: California’s AB 2697 would let licensed cannabis retailers add drive-thru windows, aiming to improve access for patients with mobility limits. Industry Labor: Teamsters authorized a strike at Ascend Wellness in Illinois over wages, health care, and workplace protections. Enforcement on the Ground: Nevada County and CDFW eradicated 14,619 illegal cannabis plants, seizing processed cannabis and arresting two people. Medical Market Expansion: Harrison County, Mississippi denied an appeal and approved a medical cannabis dispensary/process facility. Public Health & Safety: Reports highlight high-potency cannabis risks tied to psychosis and addiction debates, while a separate case notes a teen e-bike crash involving cannabis use.

Medical Cannabis Access (US): Alabama’s first legal medical dispensary, Callie’s Apothecary in Montgomery, has opened, letting patients buy physician-authorized products after years of delays, with more storefronts planned across the Gulf Coast. Regulation & Travel (US): TSA updated its medical marijuana travel guidance, clarifying that compliant medical products may be allowed in carry-on and checked baggage, while enforcement still hinges on federal rules. Industry & Compliance (Pets/Wellness): KND Labs president Nicholas Wilson was elected to the National Animal Supplement Council board as the company expands beyond hemp-derived work into broader animal and human wellness manufacturing. Business Moves (Canada): Red White & Bloom’s Emblem Cannabis closed its acquisition of Ayurcann’s Health Canada-licensed manufacturing operations, boosting vape and pre-roll brands and distribution. Public Health Debate: A new report highlights rising concerns around high-potency cannabis and mental health risks, including psychosis and addiction worries. Policy Fight (Idaho): Idaho lawmakers approved ballot language for a constitutional amendment that would block voters from legalizing marijuana via initiative. CBD/THC Drinks Watch: A US rule aimed at limiting intoxicating hemp-derived snacks and drinks could hit the fast-growing THC beverage market later this year.

CBD Coverage Update: The FDA says it won’t interfere with a CMS Medicare/Medicaid pilot that covers certain hemp-derived CBD products (up to $500/year) with tight THC limits; inhalable CBD is excluded. Travel & Safety: TSA updated its “What Can I Bring?” guidance for medical marijuana, stressing patients can carry state-licensed meds for use after arrival, not on the plane. Public Health & Youth: Fiji doctors report kids as young as Year 4/primary school starting cannabis or meth, with families often learning only after hospital visits. Medical Cannabis Access: Israel’s rehab system is scaling up for wounded soldiers, with mental health services a major focus. Industry & Regulation: Washington regulators warn federal rescheduling uncertainty and ongoing oversupply are pressuring the legal market. Community Impact: A Colorado county crackdown shows odor-control tech is becoming a compliance must for cannabis growers. Health Risks in Focus: A Q&A on COPD notes smoking history (tobacco and marijuana) can fit COPD, but diagnosis needs proper lung testing.

Federal Policy & Market Pressure: Washington’s legal cannabis industry is bracing for uncertainty tied to federal rescheduling, while regulators say oversupply is squeezing prices and illicit sales remain “thriving.” Travel & Patient Safety: TSA updated medical marijuana guidance, stressing patients should separate travel from dosing and use cannabis only after arriving, with airlines still banning smoking/vaping onboard. Medical Cannabis Access (Kentucky): An executive order expands medical cannabis access by adding new qualifying conditions. Regulation & Enforcement (Virginia): Virginia lawmakers are trying again to build a regulated adult-use cannabis market after a governor veto, even as hemp-derived CBD/THC products already circulate. CBD/Health Research: Studies highlight cannabis’s role in health conversations—from potential calming effects in Alzheimer’s models to findings that sleep habits tied to brain aging may matter for long-term wellness. Public Health & Youth Risks: New reporting flags ongoing concerns about cannabis use among teens and the need for clearer risk messaging.

Medical Access & Regulation: Kentucky opened a new medical cannabis dispensary in Bowling Green, with staff helping patients get cards on-site, as Gov. Andy Beshear expands qualifying conditions via executive order. Research & Health Claims: A mouse study suggests inhaled CBD may calm brain inflammation pathways tied to Alzheimer’s, but it’s not human proof. Public Health & Youth: A new Minnesota law asks the Office of Cannabis Management to explore a “magic mushrooms” pilot for PTSD and depression, while a college-student study finds problematic cannabis involvement is common. Policy Pushback: Washington’s cannabis regulators say federal rescheduling uncertainty and oversupply are pressuring the market, and Virginia lawmakers keep negotiating after a vetoed attempt to build a regulated recreational marketplace. Enforcement & Safety: Hong Kong Customs seized 16 kg of cannabis buds and 3.4 kg of cocaine at the airport; Missouri’s AG secured a deal to halt kratom/7-OH sales in-state. CBD/Industry Watch: Philadelphia passed bills tightening smoke-shop rules, including permits and testing for kratom and hemp-derived THC.

Medical Cannabis Access: Kentucky opened a new medical dispensary in Bowling Green, aiming to cut travel for cardholders and speed up card applications after Gov. Beshear expanded qualifying conditions. CBD/Alzheimer’s Research: A new mouse study reports inhaled CBD may calm brain immune overactivity tied to Alzheimer’s, lowering pro-inflammatory signals (early-stage, not human proof). Public Health & Regulation: Denver seized unregulated “PolkaDot” mushroom-infused chocolate and gummies after tests found illegal psychoactive ingredients, highlighting supplement loopholes and false labeling. Local Enforcement: Philadelphia City Council passed bills to tighten smoke shop rules, including permits, testing, and age limits for kratom and hemp-based THC, plus penalties for landlords. Cannabis in the Courts: A Missouri AG deal forces CBD American Shaman to suspend in-state kratom and 7-OH sales after claims of misleading marketing. Drug Safety/Incidents: A Winter Haven mother was arrested after a child accidentally shot himself; deputies also found cannabis in plain view. Industry/Markets: Trulieve announced it will list on the NYSE, signaling continued momentum for cannabis companies.

Kentucky Medical Access: New medical cannabis dispensaries opened in Bowling Green, with staff helping patients navigate card applications as Gov. Andy Beshear expands qualifying conditions via executive order. Research & Health Claims: A Swiss study in Communications Medicine reports cannabis use in young men may not lower testosterone and could raise it, while separate college-focused research finds problematic cannabis involvement is not rare among students. CBD for Brain Inflammation: New preclinical reporting suggests CBD may calm Alzheimer’s-linked neuroinflammation in mice. Policy & Legal Pressure: Minnesota’s Office of Cannabis Management is exploring “magic mushroom” legality through a possible pilot, while Philadelphia passed bills to tighten smoke shop rules around kratom and hemp-derived THC. Enforcement vs. Defiance: In Barrie, psilocybin and unlicensed cannabis shops reopened despite raids and a proposed “zero-tolerance” policy. Industry & Markets: Trulieve announced a NYSE listing, and TerrAscend moved toward a shareholder vote for a share consolidation aimed at meeting U.S. exchange criteria. Travel Reminder: TSA says doctor-prescribed medical marijuana is allowed, but warns enforcement can still happen if illegal items are found.

Pre-roll automation gets cheaper: RollCraft (STM Canna) says it’s selling a complete pre-roll fill-and-close line for $29,995, aiming to help smaller producers keep up as pre-rolls became the top U.S. category by units (up 18.6% in 2025). NYSE milestone for medical cannabis: Trulieve announced its subordinate shares are approved to uplist to the NYSE under ticker “TRLV” on June 10, framing it as a direct result of federal medical marijuana rescheduling to Schedule III. Federal policy pushback: A U.S. House panel advanced a bill that would block federal workers’ compensation from covering medical marijuana, even after rescheduling. Hemp CBD legal fight: The White House urged Congress to amend the definition of “final hemp-derived cannabinoid products” to keep full-spectrum hemp CBD legal as a broad ban is set to take effect later this year. Regulatory leadership in New York: The NY Senate confirmed John Kagia as executive director of the Office of Cannabis Management. Medical access expansion (Kentucky): Gov. Andy Beshear signed an order adding 15 new qualifying conditions to Kentucky’s medical cannabis program. Enforcement still active: Antigua police defended a raid that seized 500+ cannabis plants, saying the operation exceeded legal limits and lacked required licenses.

Kentucky Medical Cannabis Expansion: Gov. Andy Beshear signed an executive order that nearly quadruples qualifying conditions for medical cannabis cards in Kentucky, expanding the list from 6 to 21 and aiming to reduce confusion for patients and clinicians. Alabama Dispensary Launch: Alabama’s first licensed medical cannabis dispensary opened in Montgomery (Callie’s Apothecary), with access tightly tied to patient cards and in-person certification steps. State Revenue Update: California reported about $248M in legal cannabis tax revenue for Q1 2026, including excise and sales tax collections. Public Health & Safety: A measles alert was issued for Cairns locations, including the hospital emergency department, after possible exposure tied to a recent flight—reminding travelers to watch for symptoms. Research Watch: New findings link adolescent cannabis use with changes in brain development tied to dopamine systems, raising concerns about high-potency products. Local Regulation Push: Okanogan County is weighing tighter cannabis restrictions despite an economic analysis showing major local job and activity impacts.

Medical Cannabis Access Expands (Kentucky): Gov. Andy Beshear signed an executive order adding 15 qualifying conditions, with emergency rules to clarify eligibility for more patients. Medical Cannabis Access Expands (Louisiana): A new law lets terminally ill patients use medical marijuana in hospitals under written guidelines, with staff barred from handling it. Driving Reform (NSW, Australia): Unions NSW backed NSW’s plan to give medicinal cannabis drivers a medical defence for limited THC levels, aiming to reduce job and licence losses. Youth Risk (UK): A Blackburn with Darwen survey found 28% of schoolchildren reported using illegal THC or Spice vapes. Enforcement Crackdown (Arkansas): Agents seized 25+ pounds of illegal THC products and arrested two people tied to an unlicensed retailer. International Case (Indonesia): Police arrested an Australian woman over 59ml of cannabis vape liquid; she faces up to 20 years. Clinical Research (Kratom): FDA cleared a first human trial of mitragynine for opioid use disorder, while Missouri’s AG secured a deal to suspend kratom sales. Industry/Compliance Culture: A commentary warns cannabis firms may be overbuilding policies but underbuilding compliance culture as costs rise.

NSW Road Safety Reform: NSW is moving to let registered medicinal cannabis patients keep driving if lab THC is under 50 ng/mL, using a “three-strike” warning-and-penalty approach while still keeping roadside testing and bans for most drivers. Kentucky Access Update: Gov. Andy Beshear issued an executive order clarifying qualifying conditions, aiming to expand medical cannabis eligibility beyond earlier confusion in the statute. Alabama Launch Milestone: Alabama’s first state-sanctioned medical marijuana purchase was made in Montgomery, with the first dispensary opening and patients with conditions like multiple sclerosis starting treatment. New York Leadership: New York’s Senate confirmed John Kagia to lead the Office of Cannabis Management, as the state continues tightening its legal market and enforcement. EU Crackdown on CBD Foods/Flowers: Europe is tightening rules on non-psychoactive cannabis products, with France moving to end tolerance for CBD edibles under “novel food” requirements. Health & Research: A Swiss study links cannabis use in young men with higher testosterone, while other coverage highlights ongoing concerns about youth vaping content on TikTok.

Medical Access Expansion (Kentucky): Gov. Andy Beshear signed an executive order adding 15 qualifying conditions to Kentucky’s medical cannabis program, aiming to clear confusion in the statute and broaden access for patients who rely on cannabis as an alternative to opioids. Road Safety Reform (NSW): New South Wales is moving toward a “commonsense” driving approach for registered medicinal cannabis users, replacing automatic penalties with a threshold system, warnings, and escalating consequences only after repeat positives. Adult-Use Market Stalled (Virginia): Virginia’s retail cannabis framework remains in limbo after Gov. Abigail Spanberger vetoed the adult-use sales bill, leaving possession legal but no regulated shop market. Program Launch (Alabama): Alabama’s medical cannabis era begins with Callie’s Apothecary opening in Montgomery, while patients in other areas wait for additional dispensaries. Research & Policy Pressure (Michigan): A Michigan State researcher says federal rules force studies on low-potency cannabis, making it harder to understand real-world health risks from products sold in dispensaries. Youth Health Signal: A new study links dual cannabis vaping and smoking in young adults with higher odds of respiratory symptom onset, raising more questions for public health guidance. Regulatory Tension (Massachusetts): Hopkinton voted to seek a waiver to opt out of statewide cannabis delivery, citing youth access and normalization concerns.

Medical Access Expansion (Kentucky): Gov. Andy Beshear signed an executive order adding 15 qualifying conditions to Kentucky’s medical cannabis program, bringing the list to include terminal illness, ALS, Parkinson’s, HIV/AIDS, Crohn’s, ulcerative colitis, severe arthritis, fibromyalgia, glaucoma, and more—aimed at giving patients a “safe, non-addictive” option. Policy & Legal Pushback (Hemp THC): A House Rules Committee blocked amendments that would have kept hemp THC products federally legal or delayed recriminalization, keeping the November crackdown on the table. Clinical Conversations (Older Adults): Rutgers Health research found fewer than 1 in 5 adults over 65 discuss cannabis use with clinicians, underscoring a need for better patient-provider conversations. Product Safety (Colorado): Colorado regulators issued a recall for two brands of THC vapes after banned flavor compounds were found in vape oil. Terminal-Ill Patient Rights (Pennsylvania): Pennsylvania lawmakers advanced “Ryan’s Law,” requiring hospitals to allow approved medical cannabis use for terminally ill patients. Research Limits (Michigan): A Michigan State researcher says federal rules restrict cannabis research to low-potency products that don’t match what people buy in dispensaries. Local Governance (Massachusetts): A town board voted to recommend opting out of new cannabis delivery rules via a waiver.

Federal Rescheduling Watch: The DOJ’s move to reclassify medical cannabis from Schedule I to Schedule III is opening doors for more research and potential tax benefits, but the broader federal-state split still leaves states navigating patchy rules. Clinical Education Push: TheAnswerPage.com rolled out a new 6-credit CME/CE bundle to help clinicians handle cannabis in practice, including use disorder and CHS counseling. State Policy Updates: Minnesota signed a bill streamlining medical and adult-use supply chains, while Oregon begins enforcing its hemp registry rules for CBD/THC product registration. Market Pressure: Oklahoma growers warn oversupply is crushing wholesale prices, turning the “boom” into a squeeze. Public Health & Safety: Louisiana’s governor signed a bill that can jail people for smoking marijuana near school properties, and Czech authorities stepped up enforcement against dangerous synthetic cannabinoid products and illegally sold kratom. Legal/Consumer Risk: A federal lawsuit in Illinois compares cannabis marketing tactics to Big Tobacco, alleging major firms downplayed risks while promoting medical claims. Youth & Brain Health: New research links cannabis plus tobacco co-use with worse cognitive performance in people at clinical high risk for psychosis.